Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 39 (1) , 1-13
- https://doi.org/10.1016/s0169-5002(02)00382-3
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Evolution, immune response, and cancerThe Lancet, 2000
- Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancerLung Cancer, 2000
- Chemotherapy versus palliative care in non-small cell lung cancerAnti-Cancer Drugs, 2000
- Treatment and Outcomes for Elderly Patients with Small Cell Lung CancerDrugs & Aging, 2000
- The plasmin cascade and matrix metalloproteinases in non-small cell lung cancerThorax, 1999
- CHART for non-small-cell lung cancer-promises and limitationsThe Lancet, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996Lung Cancer, 1997
- Treatment of metastatic non-small cell lung cancerCurrent Opinion in Oncology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995